Literature DB >> 20551450

The next thing in prognostic molecular markers: microRNA signatures of cancer.

William M Grady1, Muneesh Tewari.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20551450      PMCID: PMC3377960          DOI: 10.1136/gut.2009.200022

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  33 in total

1.  p21 expression is a prognostic factor in patients with p53-negative gastric cancer.

Authors:  C Xiangming; S Hokita; S Natsugoe; G Tanabe; M Baba; S Takao; K Kuroshima; T Aikou
Journal:  Cancer Lett       Date:  2000-02-01       Impact factor: 8.679

Review 2.  MicroRNAs: genomics, biogenesis, mechanism, and function.

Authors:  David P Bartel
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

3.  Identification of prognostic biomarkers in gastric cancer using endoscopic biopsy samples.

Authors:  Yasuhide Yamada; Tokuzo Arao; Takuji Gotoda; Hirokazu Taniguchi; Ichiro Oda; Kuniaki Shirao; Yasuhiro Shimada; Tetsuya Hamaguchi; Ken Kato; Tetsutaro Hamano; Fumiaki Koizumi; Tomohide Tamura; Daizo Saito; Tadakazu Shimoda; Makoto Saka; Takeo Fukagawa; Hitoshi Katai; Takeshi Sano; Mitsuru Sasako; Kazuto Nishio
Journal:  Cancer Sci       Date:  2008-01-11       Impact factor: 6.716

4.  Decreased xanthine oxidoreductase is a predictor of poor prognosis in early-stage gastric cancer.

Authors:  N Linder; C Haglund; M Lundin; S Nordling; A Ristimäki; A Kokkola; J Mrena; J-P Wiksten; J Lundin
Journal:  J Clin Pathol       Date:  2006-09       Impact factor: 3.411

5.  Prognostic impact of stromal cell-derived urokinase-type plasminogen activator in gastric carcinoma.

Authors:  Y Okusa; T Ichikura; H Mochizuki
Journal:  Cancer       Date:  1999-03-01       Impact factor: 6.860

6.  Characterization of the 13q14 tumor suppressor locus in CLL: identification of ALT1, an alternative splice variant of the LEU2 gene.

Authors:  F Bullrich; H Fujii; G Calin; H Mabuchi; M Negrini; Y Pekarsky; L Rassenti; H Alder; J C Reed; M J Keating; T J Kipps; C M Croce
Journal:  Cancer Res       Date:  2001-09-15       Impact factor: 12.701

7.  Interleukin 8 and vascular endothelial growth factor -- prognostic factors in human gastric carcinomas?

Authors:  S Kido; Y Kitadai; N Hattori; K Haruma; T Kido; M Ohta; S Tanaka; M Yoshihara; K Sumii; Y Ohmoto; K Chayama
Journal:  Eur J Cancer       Date:  2001-08       Impact factor: 9.162

8.  An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans.

Authors:  N C Lau; L P Lim; E G Weinstein; D P Bartel
Journal:  Science       Date:  2001-10-26       Impact factor: 47.728

9.  CagA status of Helicobacter pylori infection and p53 gene mutations in gastric adenocarcinoma.

Authors:  Atsuko Shibata; Julie Parsonnet; Teri A Longacre; Maria Isabel Garcia; Balaram Puligandla; R Eric Davis; Joseph H Vogelman; Norman Orentreich; Laurel A Habel
Journal:  Carcinogenesis       Date:  2002-03       Impact factor: 4.944

10.  Biochemical and genetic interaction between the fragile X mental retardation protein and the microRNA pathway.

Authors:  Peng Jin; Daniela C Zarnescu; Stephanie Ceman; Mika Nakamoto; Julie Mowrey; Thomas A Jongens; David L Nelson; Kevin Moses; Stephen T Warren
Journal:  Nat Neurosci       Date:  2004-01-04       Impact factor: 24.884

View more
  30 in total

Review 1.  MicroRNA binding-site polymorphisms as potential biomarkers of cancer risk.

Authors:  Rachel C Blitzblau; Joanne B Weidhaas
Journal:  Mol Diagn Ther       Date:  2010-12-01       Impact factor: 4.074

2.  Plasma miRNA-122-5p and miRNA-151a-3p identified as potential biomarkers for liver injury among CHB patients with PNALT.

Authors:  Jin-Lin Cheng; Hong Zhao; Shi-Gui Yang; Er-Mei Chen; Wen-Qian Chen; Lan-Juan Li
Journal:  Hepatol Int       Date:  2018-06-07       Impact factor: 6.047

Review 3.  Small non-coding RNAs in human cancer: function, clinical utility, and characterization.

Authors:  Zhao Zhang; Jian Zhang; Lixia Diao; Leng Han
Journal:  Oncogene       Date:  2021-01-15       Impact factor: 9.867

4.  Circulating MicroRNAs and Life Expectancy Among Identical Twins.

Authors:  Shenghui Wu; Taek-Kyun Kim; Xiaogang Wu; Kelsey Scherler; David Baxter; Kai Wang; Ruth E Krasnow; Terry Reed; Jun Dai
Journal:  Ann Hum Genet       Date:  2016-07-12       Impact factor: 1.670

5.  Therapeutic targeting of the phosphatidylinositol 3-kinase signaling pathway: novel targeted therapies and advances in the treatment of colorectal cancer.

Authors:  Ming Yu; William M Grady
Journal:  Therap Adv Gastroenterol       Date:  2012-09       Impact factor: 4.409

6.  Exosome-encapsulated microRNA-223-3p as a minimally invasive biomarker for the early detection of invasive breast cancer.

Authors:  Mio Yoshikawa; Hisae Iinuma; Yasuko Umemoto; Takako Yanagisawa; Akiko Matsumoto; Hiromitsu Jinno
Journal:  Oncol Lett       Date:  2018-04-10       Impact factor: 2.967

7.  Mathematical model identifies blood biomarker-based early cancer detection strategies and limitations.

Authors:  Sharon S Hori; Sanjiv S Gambhir
Journal:  Sci Transl Med       Date:  2011-11-16       Impact factor: 17.956

8.  Exosomal microRNA in plasma as a non-invasive biomarker for the recurrence of non-small cell lung cancer.

Authors:  Hitoshi Dejima; Hisae Iinuma; Rie Kanaoka; Noriyuki Matsutani; Masafumi Kawamura
Journal:  Oncol Lett       Date:  2017-01-04       Impact factor: 2.967

9.  MiR-216b functions as a tumor suppressor by targeting HMGB1-mediated JAK2/STAT3 signaling way in colorectal cancer.

Authors:  Xiaoxiang Chen; Xiangxiang Liu; Bangshun He; Yuqin Pan; Huiling Sun; Tao Xu; Xiuxiu Hu; Shukui Wang
Journal:  Am J Cancer Res       Date:  2017-10-01       Impact factor: 6.166

Review 10.  MicroRNAs (miRNAs) as biomarker(s) for prognosis and diagnosis of gastrointestinal (GI) cancers.

Authors:  Muzafar A Macha; Parthasarathy Seshacharyulu; Shiv Ram Krishn; Priya Pai; Satyanarayana Rachagani; Maneesh Jain; Surinder K Batra
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.